Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
SGS has invested in a new Genotypic DNA sequencing MicroSeq® Rapid Microbial Identification System from Applied Biosystems at its Chicago, IL facility, located in the suburb of Lincolnshire.
read more
CellCarta announced the appointment of Ehab A. El-Gabry, MD, as Chief Medical Officer and Head of Companion Diagnostics. In this role, Dr. El-Gabry will provide medical and scientific leadership across CellCarta's biomarker programs and lead the ...
read more
Catalent is set to launch its new OneBio Suite for the integrated development, manufacturing, and clinical supply of biologic drugs.
read more
Thursday, October 07, 2021
Peli BioThermal announced the relocation of its Minnesota-based corporate headquarters from Plymouth to Maple Grove, MN. The new space adds 40 percent more square footage, positioning the company to meet increasing demand for thermal packaging that ...
read more
Adare Pharma Solutions, a global technology-driven CDMO focused on oral dosage forms, announced the completion of its divestiture of its Adare Biome business unit, a pioneer in the development and manufacturing of postbiotics, to dsm-firmenich, ...
read more
Thursday, August 08, 2013
Pharma Tech Industries (PTI), the largest pharmaceutical contract manufacturer and packager of powder products in the world, has announced plans to expand its production facility in Union, Missouri. The multi-million-dollar investment will add ...
read more
Wednesday, October 19, 2016
Hemispherx Biopharma has completed its technology transfer of the Ampligen® manufacturing processes to Avrio Biopharmaceuticals. The transfer consists of providing Avrio with all information that is relevant to the manufacturing process of Ampligen® ...
read more
Friday, November 04, 2022
Exelixis, Inc. and Catalent, Inc. announced a new license agreement under which Catalent’s Redwood Bioscience subsidiary will grant Exelixis an exclusive license to three target programs with lead antibody and/or ADC candidates.
read more
Tuesday, October 24, 2017
Catalent has completed the acquisition of Cook Pharmica, an integrated provider of drug substance and drug product manufacturing and related services.
read more
PAREXEL announced an alliance with CHA Medical Group (CHA) to enhance early phase clinical development in Korea.
read more
Tuesday, January 14, 2020
Valneva announced the U.S. Department of Defense has exercised an option to purchase 80,000 additional doses of its Japanese encephalitis vaccine IXIARO®.
read more
Horizon Discovery Group announced the addition of an arrayed CRISPR knockout screening service for primary human B cells to its cell-based screening services.
read more
Tuesday, December 22, 2015
QPharma, a provider of compliance and commercial services to the life sciences industry, has announced the acquisition of Qforma, Inc., a BelHealth Investment Partners portfolio company.
read more
Wednesday, December 27, 2023
The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:
read more
Wednesday, September 03, 2025
Aptamer Group ,a developer of synthetic binders for the life science industry, announced the launch of its biomarker discovery service, offering researchers in pharmaceutical, biotechnology, and diagnostic development an innovative approach to ...
read more